Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles on NLRP3 inflammasome activation in the adult mouse brain after chronic ethanol exposure.

Mellado S., Moreno-Manzano V., Guerri C., Pascual M.

Animal Study on Neuroinflammation, Chronic Inflammation, Immune Modulation, published in Mol Biol Rep (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Mol Biol Rep (2026)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
41944903
DOI
10.1007/s11033-026-11774-2

Abstract (original English)

Background NOD-like receptors (NLRs) and inflammasome complexes play critical roles in the neuroinflammatory responses triggered by chronic ethanol exposure. We previously demonstrated that mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) attenuated binge-like alcohol consumption-induced NLRP3 inflammasome activation in the adolescent hippocampus; however, their broader effects on additional NLR pathways and brain regions remained unclear. Methods and Results This study investigates the therapeutic potential of intravenously administered adipose-derived MSC-EVs (20 µg/dose every 10 days) in a murine model of chronic alcoholism, established by providing 10% ethanol in drinking water for three months. We specifically focused on changes in the expression of inflammasome sensor genes (Nlrp3, Nlrc4, Nlrp1, and Aim2) and downstream effector genes (Casp-1, Casp-11/4, Il1b, and Il18) across the prefrontal cortex, hippocampus, and striatum. qPCR analysis revealed that chronic ethanol exposure significantly upregulated the expression of the noted inflammasome-related genes in all three brain regions. MSC-EV treatment normalized the ethanol-induced overexpression of inflammasome sensor and downstream effector genes, suggesting the broad attenuation of inflammasome-driven neuroinflammatory responses. Conclusions These findings, together with our previous results, further expa

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesMiceMesenchymal Stem CellsEthanolExtracellular VesiclesBrainMaleDisease Models, Animal

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research